FilingSEC EDGARSCHEDULE 13D/ABridgeBio Pharma, Inc. filed Form SCHEDULE 13D/AJul 10, 2026, 19:03 ET · SEC acceptedSummaryFiling infoView sourceFiling contentPlease check the source for details.Related companiesBridgeBio Pharma, Inc.BBIOView stockLikeCommentsRepostShareComments —CommentLoading comments…
Comments —
Loading comments…